Tadalafil NDC 71205-269

Product information

Brand name (proprietary)

Tadalafil

Generic name (nonproprietary)

tadalafil

Active ingredients

Tadalafil — 5 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Proficient Rx LP

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 209167

Marketing start

Mar 27, 2019

Listing expires

Dec 31, 2026

Other FDA classes

Phosphodiesterase 5 Inhibitors (Mechanism)

Identifiers

Product ID 71205-269_40f1c753-2918-498e-a8db-acc6514cbdc9SPL ID 40f1c753-2918-498e-a8db-acc6514cbdc9SPL set ID 31c05a53-7282-46d0-81bd-108defe6fb38RxCUI 403957UNII 742SXX0ICTUPC 0371205269302

Pharmacologic class

Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205026930 followed by a unit qualifier and the quantity Copy

Package 71205-0269-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 209167

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.